Cd47 Mouse shRNA Plasmid (Locus ID 16423)
CAT#: TL501123
Cd47 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (4)
Lateral flow testing sticks used for the semi-quantitative detection of the lentiviral p24 protein, 20 tests
CNY 4,070.00
Specifications
Product Data | |
Product Name | Cd47 Mouse shRNA Plasmid (Locus ID 16423) |
Locus ID | 16423 |
UniProt ID | Q61735 |
Synonyms | 9130415E20Rik; AA407862; AI848868; AW108519; B430305P08Rik; IAP; Itgp |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | Cd47 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 16423). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | BC012667, NM_010581, NM_010581.1, NM_010581.2, NM_010581.3, BC009094, NM_001368415, NM_001368416, NM_001368417, NM_001368418 |
Summary | Has a role in both cell adhesion by acting as an adhesion receptor for THBS1 on platelets, and in the modulation of integrins. Plays an important role in memory formation and synaptic plasticity in the hippocampus. Receptor for SIRPA, binding to which prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells. Interaction with SIRPG mediates cell-cell adhesion, enhances superantigen-dependent T-cell-mediated proliferation and costimulates T-cell activation. May play a role in membrane transport and/or integrin dependent signal transduction. May prevent premature elimination of red blood cells. May be involved in membrane permeability changes induced following virus infection (By similarity).[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Targeting cluster of differentiation 47 improves the efficacy of anti-cytotoxic T-lymphocyte associated protein 4 treatment via antigen presentation enhancement in pancreatic ductal adenocarcinoma
,Song, X;Lu, Z;Xu, J;,
Exp Ther Med
,PubMed ID 32855701
[CD47]
|
High expression of CD47 predicts adverse prognosis in Chinese patients and suppresses immune response in melanoma.
,null,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
,PubMed ID 28738534
[Cd47]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...